DWAS holdings

Computed by this site from the fund's SEC Form N-PORT filing; what the measure does not tell you · every fund in one table · hold it with other funds? X-ray the mix. Pricing: 75.03% at a quoted market price (level 1), 5 issuer countries.

DWAS's largest investment is Sandisk Corp at 2.95% of net assets. Sezzle Inc and Planet Labs PBC follow; the three together are 7.55%. Ten companies are 16.66% of the fund; the other 190 share the rest. Among the 721 equity funds measured here, DWAS behaves like 135.4 holdings against a median of 42.4 — 3.2 times the median. Across 27 quarterly filings DWAS has held roughly steady since 2019-11-30 (147.4 then, 135.4 now). Between the 2026-02-28 and 2026-05-31 filings 95 positions were added and 96 dropped; 49.5% of the weight moved.

Each sentence is read from the fund's own SEC filing; the class median is computed across the comparable equity funds on this site. Nothing here is a view on the fund.

Between 2019-11-30 and 2026-05-31, DWAS went from behaving like 147.4 equally weighted positions to 135.4 — 8% fewer, while its top ten went from 15.35% to 16.66% of net assets. Read across the funds on the concentration-over-time table.

One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.

DWAS's filing lists 202 positions including 33.3% of net assets in securities-lending cash collateral. Counted as filed the fund reads 13.6 effective holdings with a top ten of 47.7%; on its own investments — the figure above — it reads 135.4 with a top ten of 16.66%. The collateral is matched by a liability and is not a holding the fund chose; since 2026-09-18 every figure on this site sets it aside (methodology). Both numbers are in the data.

The 15 largest of 200 positions in DWAS's Form N-PORT, weight as a share of net assets, securities-lending collateral excluded. Every position, every quarter: DWAS.csv.gz.

Share of DWAS's own investments by the issuer country the filer reported (incorporation, not revenue). Each country links to every fund that holds it.

Monthly total returns from Item B.5 of DWAS's own filings, 81 months on record. Not computed here and not from a price feed.

Cross-checked against a series computed separately from prices: median difference — percentage points over 0 months, which is roughly the distributions. Every month with the filing it came from: DWAS.json · all funds.

The fund lends its holdings, and Item B.4.a of the filing names every firm holding them. At 2026-05-31, $136m was out to 23 borrowers, 32.51% of net assets. The largest, BNP PARIBAS PRIME BROKERAGE INTERNATIONAL LIMITED, held 16.3% of it.

Cash collateral reported against the loan: 33.30% of net assets, 102.4% of the amount lent. That is a floor on the collateral, not the whole of it — collateral the fund does not hold as a position is not in this filing, so a figure under 100% is not evidence of under-collateralisation. How that figure behaves across all funds. Every quarter DWAS has filed, with each borrower: DWAS.json · all funds.

201 positions became 200: 95 added (45.3% of the fund at the later date), 96 dropped (39.3% at the earlier date). Half the sum of all weight changes, a turnover proxy: 49.5%. Positions are matched on identifiers, so a security whose identifier changed shows as one drop and one add. Every filing of DWAS compared this way, as a feed: changes.xml · all funds: filings received.

New: Sandisk Corp. (2.95%), Ondas Inc. (1.32%), Tango Therapeutics Inc. (1.31%), Viasat, Inc. (1.13%), Heritage Insurance Holdings, Inc. (0.97%), Aehr Test Systems (0.96%). Gone: Terns Pharmaceuticals, Inc. (1.58%), Tutor Perini Corp. (1.49%), Frequency Electronics, Inc. (1.08%), Idaho Strategic Resources, Inc. (1.01%), RAPT Therapeutics, Inc. (0.88%), Inhibrx Biosciences, Inc. (0.78%).

74.98% equity, 25.02% short-term investment as filed; 75.0% carried at a quoted market price (fair-value level 1). Categories and levels are the filer's; what a low level-1 share does and does not mean is in the measure's page.

Every measured equity fund lined up by how many holdings it behaves like; these sit either side of DWAS (135.4). Same filings, same arithmetic. Position in this list says nothing about which fund is better.